CN101384728A - 意识障碍患者的病态检测方法和检测试剂盒 - Google Patents
意识障碍患者的病态检测方法和检测试剂盒 Download PDFInfo
- Publication number
- CN101384728A CN101384728A CNA2007800056433A CN200780005643A CN101384728A CN 101384728 A CN101384728 A CN 101384728A CN A2007800056433 A CNA2007800056433 A CN A2007800056433A CN 200780005643 A CN200780005643 A CN 200780005643A CN 101384728 A CN101384728 A CN 101384728A
- Authority
- CN
- China
- Prior art keywords
- detection
- adamts13
- von willebrand
- consciousness
- disturbance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
Abstract
Description
Claims (10)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006039567 | 2006-02-16 | ||
JP039567/2006 | 2006-02-16 | ||
PCT/JP2007/052697 WO2007094394A1 (ja) | 2006-02-16 | 2007-02-15 | 意識障害患者における病態の検出方法及び検出用キット |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101384728A true CN101384728A (zh) | 2009-03-11 |
CN101384728B CN101384728B (zh) | 2013-05-22 |
Family
ID=38371573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007800056433A Expired - Fee Related CN101384728B (zh) | 2006-02-16 | 2007-02-15 | 意识障碍患者的病态检测方法和检测试剂盒 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9297815B2 (zh) |
EP (1) | EP1990421B1 (zh) |
JP (1) | JP5221333B2 (zh) |
KR (1) | KR101366724B1 (zh) |
CN (1) | CN101384728B (zh) |
CA (1) | CA2642546A1 (zh) |
ES (1) | ES2386574T3 (zh) |
WO (1) | WO2007094394A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8088624B2 (en) * | 2003-12-22 | 2012-01-03 | Mitsubishi Kagaku Iatron, Inc. | Method of detecting thrombosis by measuring von Willenbrand factor-cleaving protease |
EP1816211A4 (en) * | 2004-11-08 | 2008-11-12 | Mitsubishi Kagaku Iatron Inc | METHOD OF DETECTING THROMBOSIS OF BLOOD PLAQUETTES OR DEGASTS TO AN ORGAN |
AU2007210643B2 (en) * | 2006-01-31 | 2013-09-19 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Method for determination of condition of disseminated intravascular coagulation syndrome |
US8945895B2 (en) | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
JP5648905B2 (ja) * | 2010-11-12 | 2015-01-07 | 株式会社Lsiメディエンス | 肝臓がん発症の検出又はリスクの予測方法 |
JPWO2012067152A1 (ja) * | 2010-11-16 | 2014-05-12 | 三菱化学株式会社 | EndothelialProteinCReceptor蛋白質による脳梗塞の検査方法 |
EP3526339A1 (en) | 2016-10-11 | 2019-08-21 | Laboratory Corporation of America Holdings | Methods and systems for determining adamts13 enzyme activity |
RU2648515C1 (ru) * | 2016-12-21 | 2018-03-26 | Общество с ограниченной ответственностью "ДРД" | Прогнозирование течения и исхода комы и посткоматозных бессознательных состояний (в том числе вегетативных) с помощью гемотестов |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE430578T1 (de) * | 1999-12-24 | 2009-05-15 | Chemo Sero Therapeut Res Inst | Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen |
WO2001047558A1 (fr) * | 1999-12-28 | 2001-07-05 | Kaken Pharmaceutical Co., Ltd. | Medicaments protegeant les nerfs |
WO2003016492A2 (en) * | 2001-08-16 | 2003-02-27 | The Regents Of The University Of Michigan | Adamts13 genes and proteins and variants, and uses thereof |
DE60331666D1 (de) | 2002-09-25 | 2010-04-22 | Chemo Sero Therapeut Res Inst | Antikörper gegen ein den von-willebrand-faktor spezifisch spaltendes enzym und assay-system unter verwendung davon |
AU2003903412A0 (en) * | 2003-07-04 | 2003-07-17 | Adelaide Research & Innovation Pty Ltd | Mutation associated with strokes |
US8088624B2 (en) | 2003-12-22 | 2012-01-03 | Mitsubishi Kagaku Iatron, Inc. | Method of detecting thrombosis by measuring von Willenbrand factor-cleaving protease |
EP1816211A4 (en) | 2004-11-08 | 2008-11-12 | Mitsubishi Kagaku Iatron Inc | METHOD OF DETECTING THROMBOSIS OF BLOOD PLAQUETTES OR DEGASTS TO AN ORGAN |
-
2007
- 2007-02-15 ES ES07714227T patent/ES2386574T3/es active Active
- 2007-02-15 WO PCT/JP2007/052697 patent/WO2007094394A1/ja active Application Filing
- 2007-02-15 KR KR1020087020983A patent/KR101366724B1/ko active IP Right Grant
- 2007-02-15 EP EP07714227A patent/EP1990421B1/en not_active Expired - Fee Related
- 2007-02-15 CA CA002642546A patent/CA2642546A1/en not_active Abandoned
- 2007-02-15 JP JP2008500539A patent/JP5221333B2/ja active Active
- 2007-02-15 CN CN2007800056433A patent/CN101384728B/zh not_active Expired - Fee Related
- 2007-02-15 US US12/279,418 patent/US9297815B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP5221333B2 (ja) | 2013-06-26 |
KR101366724B1 (ko) | 2014-02-25 |
US9297815B2 (en) | 2016-03-29 |
CA2642546A1 (en) | 2007-08-23 |
EP1990421A1 (en) | 2008-11-12 |
EP1990421B1 (en) | 2012-06-13 |
JPWO2007094394A1 (ja) | 2009-07-09 |
CN101384728B (zh) | 2013-05-22 |
ES2386574T3 (es) | 2012-08-23 |
KR20080094802A (ko) | 2008-10-24 |
EP1990421A4 (en) | 2009-07-15 |
US20090220990A1 (en) | 2009-09-03 |
WO2007094394A1 (ja) | 2007-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101384728B (zh) | 意识障碍患者的病态检测方法和检测试剂盒 | |
Myers et al. | CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the laboratory science discussion group | |
JP5571657B2 (ja) | 生着不全および死に関するマーカー | |
Coudrey | The troponins | |
JP6944449B2 (ja) | 対象の細胞外液量状態のマーカーとしてのMR−proADM | |
Horvath et al. | Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases | |
Iliou et al. | Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study | |
Tate et al. | Practical considerations for the measurement of free light chains in serum | |
Mojiminiyi et al. | Evaluation of cystatin C and β-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus | |
US9983212B2 (en) | In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant, a neurodegenerative disorder or a depression | |
Khan et al. | Diagnostic performance of high-sensitivity troponin T, myeloperoxidase, and pregnancy-associated plasma protein A assays for triage of patients with acute myocardial infarction | |
JP2004529351A (ja) | 急性心筋梗塞および他の臨床的状態の診断への改良 | |
US20110177531A1 (en) | Cell-Based Complement Activation Product Algorithm for Diagnosing Systemic Lupus Erythematosus | |
AU2011311765B2 (en) | A new method for diagnosing hypertension as well as cardiomyopathies | |
Cheng et al. | Nighttime blood pressure decline as a predictor of renal injury in patients with hypertension: a population-based cohort study | |
Gaze | Rapid cardiovascular diagnostics | |
US20090240439A1 (en) | Predicting responses to drugs or drug cadidates | |
JP4871173B2 (ja) | 糖尿病性腎症患者の病態把握方法 | |
Jeong et al. | ENPP1 K121Q genotype not associated with coronary artery calcification in Korean patients with type 2 diabetes mellitus | |
Saenger | Pre-analytical Factors and Analytical Issues Affecting Interpretation of Cardiovascular Biomarkers | |
Wang et al. | The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease | |
Makki | Supervisor Recommendation | |
Loh | Parallel Sessions | |
Sodi | Cardiac troponins: clinical and analytical aspects | |
Calzoni et al. | UNCONFORMITIES IN DIRECT ORAL ANTICOAGULANTS REQUESTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MITSUBISHI CHEMICAL SAFETY INSTITUTE LTD. Free format text: FORMER OWNER: MITSUBISHI KAGAKU MEDICAL, INC Effective date: 20101222 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20101222 Address after: Tokyo, Japan, Japan Applicant after: Mitsubishi Chemical Safety Institute Ltd. Address before: Tokyo, Japan, Japan Applicant before: Mitsubishi Kagaku Medical, INC |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: MEIDI ENSI LIFE TECHNOLOGY CO., LTD. Free format text: FORMER NAME: MITSUBISHI CHEMICAL SAFETY INSTITUTE LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Tokyo, Japan, Japan Patentee after: MITSUBISHI CHEM MEDIENCE CORP Address before: Tokyo, Japan, Japan Patentee before: Mitsubishi Chemical Safety Institute Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130522 Termination date: 20210215 |